Call 24/7
Chemical Addictions Program Inc cap/pegasus is an addiction treatment facility situated at 1151 Air Base Boulevard in the 36108 zip code in Montgomery, AL. It specializes in [4OpioidMedicationsUsedInTreatment]. Some of the treatment approaches used by Chemical Addictions Program Inc cap/pegasus include relapse prevention, motivational interviewing and anger management. Chemical Addictions Program Inc cap/pegasus provides regular outpatient treatment, outpatient treatment and intensive outpatient treatment. It also provides substance use treatment and co-occurring mental health and drug abuse disorders. Other addiction treatment offered includes treatment for gambling disorder.
Address: 1151 Air Base Boulevard, Montgomery, AL 36108
Here are the full facility listing details on Chemical Addictions Program Inc (CAP)/Pegasus in Montgomery, AL:
Types of Care:
Service Settings:
External Opioid Medications Source:
Type of Alcohol Use Disorder Treatment:
External Source of Medications Used for Alcohol Use Disorder Treatment:
Treatment Approaches:
Facility Ownership:
License/Certification/Accreditation:
Payment/Insurance/Funding Accepted:
Payment Assistance Available:
Assessment/Pre-treatment:
Screening & Testing:
Transitional Services:
Ancillary Services:
Other Addictions Treatment:
Counseling Services and Education:
Tobacco/Screening Services:
Facility Smoking Policy:
Age Groups Accepted:
Gender Accepted:
Services for deaf:
Phone #: 334-269-2150
Call (888) 721-7078 for 24/7 help with treatment.
Suboxone, which is a brand name for a medication containing buprenorphine and naloxone, is commonly used in addiction treatment at facilities such as Chemical Addictions Program Inc (CAP)/Pegasus, particularly for opioid addiction. Suboxone has several benefits when used as part of a comprehensive addiction treatment program:
Reduces cravings: Suboxone helps reduce cravings for opioids, making it easier for individuals to resist the urge to use opioids and stay in recovery.
Withdrawal symptom relief: It can alleviate withdrawal symptoms that can be severe and uncomfortable when someone stops using opioids. This can make the detoxification process more manageable.
Long-lasting effects: Suboxone has a long duration of action, typically lasting 24 to 36 hours per dose. This means that individuals don't have to take it multiple times a day, which can improve compliance and stability in their recovery.
Reduced risk of overdose: Because Suboxone contains naloxone, an opioid antagonist, it can deter misuse of the medication. If someone tries to inject or misuse Suboxone, the naloxone can precipitate withdrawal symptoms, discouraging misuse.
Improved retention in treatment: Suboxone treatment can help individuals stay engaged in addiction treatment programs for longer periods. This increases their chances of success in achieving and maintaining sobriety.
Lower risk of infectious diseases: By reducing the use of illicit opioids and the sharing of needles, Suboxone can contribute to a decreased risk of contracting diseases like HIV or hepatitis.
Improved quality of life: When used as part of a comprehensive treatment plan that includes counseling and support, Suboxone can help individuals regain control over their lives, maintain stable employment, and rebuild relationships.
Reduced criminal activity: Participation in Suboxone treatment is associated with a decreased likelihood of engaging in criminal activities related to drug use.
Enhanced safety: Unlike illicit opioids, Suboxone is regulated and obtained through legal channels, reducing the risk of exposure to adulterated or dangerous substances.
Suboxone treatment is most effective when used as part of a comprehensive addiction treatment program at a rehab center like Chemical Addictions Program Inc (CAP)/Pegasus, which may include counseling, therapy, and support services. It is not a standalone solution but can be a valuable tool in the process of addiction recovery. Additionally, Suboxone should be prescribed and managed by healthcare professionals with expertise in addiction medicine to ensure safe and effective use.
Other drug and rehab centers within 75 miles of Chemical Addictions Program Inc (CAP)/Pegasus:
Suboxone is generally considered safe and effective at helping individuals overcome opioid addiction. However, like many medications, it does have the potential for misuse and addiction, especially when not used as directed.
Here are some important points to consider:
Addiction Potential: Suboxone contains buprenorphine, which is a partial opioid agonist. While it is less likely to cause the intense euphoria and cravings associated with full opioid agonists like heroin, it can still lead to physical dependence and, in some cases, psychological addiction when misused.
Tolerance and Dependence: Even when used as prescribed, some individuals may develop a tolerance to Suboxone over time, requiring higher doses to achieve the same effect. This can potentially lead to dependence on the medication.
Diversion and Misuse: Suboxone can be diverted and misused by individuals who do not have a legitimate need for it. Some people may seek Suboxone for its opioid effects rather than for addiction treatment.
Withdrawal: If someone becomes dependent on Suboxone and suddenly stops taking it, they can experience withdrawal symptoms, which may be uncomfortable and drive continued use.
Treatment Under Supervision: The most effective way to minimize the risk of Suboxone misuse and addiction is to use it as part of a comprehensive addiction treatment program under the supervision of a healthcare provider. This includes regular monitoring, counseling, and support to address the underlying causes of addiction.
The risk of addiction with Suboxone is generally much lower than with full opioid agonists, and it has been shown to be an effective tool in helping individuals break the cycle of opioid addiction. The benefits of using Suboxone to treat opioid addiction at a treatment center like Chemical Addictions Program Inc (CAP)/Pegasus often outweigh the potential risks, especially when used within a well-designed treatment plan.